Mayo Clinic, W. L. Gore & Associates announce Avobis Bio, a joint venture for new regenerative therapies

“Based on promising results in an early clinical trial, Mayo Clinic has formed a new joint venture with materials engineering firm W.L. Gore & Associates to spearhead a new therapy using stem cells to repair a painful tissue problem stemming from Crohn's disease.”

Congratulations to our founder, Dr. Allan Dietz, on the exciting news! Our platelet lysate, PLTMax®, was used to manufacture the cells for the clinical trial, as well as other studies at Mayo. Platelet lysate is a key component in growing these stem cells.